Hisamitsu Pharmaceutical Co Inc (4530) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain-relieving products, dermatological products and quasi-drugs, among others. Hisamitsu Pharmaceutical provides its products in various forms such as patches, gel patches, gels, creams, and lotions. Its products are indicated for the relief of sore shoulders, arthritis, joint pain, back pain, strains, sprains, stiff neck, muscle fatigue, bruises, and muscle pain, among other conditions. It operates production facilities, research laboratories, and offices in Japan and serves both over-the-counter (OTC) and prescription markets. The company markets its products in Asia and the US. Hisamitsu Pharmaceutical is headquartered in Chiyoda-Ku, Tokyo, Japan.
Hisamitsu Pharmaceutical Co Inc Key Recent Developments
May 22, 2025: Hisamitsu Pharmaceutical Announces New Executive Appointments
May 17, 2025: Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Ninth Consecutive Year
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Hisamitsu Pharmaceutical Co Inc - Key Facts
Hisamitsu Pharmaceutical Co Inc - Key Employees
Hisamitsu Pharmaceutical Co Inc - Major Products and Services
Hisamitsu Pharmaceutical Co Inc - History
Hisamitsu Pharmaceutical Co Inc - Company Statement
Hisamitsu Pharmaceutical Co Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 - Company Analysis
Company Overview
Hisamitsu Pharmaceutical Co Inc - Business Description
Geographical Segment: Japan
Performance
Geographical Segment: Others
Performance
Geographical Segment: United States
Performance
R&D Overview
Hisamitsu Pharmaceutical Co Inc - Corporate Strategy
Hisamitsu Pharmaceutical Co Inc - SWOT Analysis
SWOT Analysis - Overview
Hisamitsu Pharmaceutical Co Inc - Strengths
Hisamitsu Pharmaceutical Co Inc - Weaknesses
Hisamitsu Pharmaceutical Co Inc - Opportunities
Hisamitsu Pharmaceutical Co Inc - Threats
Hisamitsu Pharmaceutical Co Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals by Year, 2019 to YTD 2025
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Hisamitsu Pharmaceutical Co Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
May 22, 2025: Hisamitsu Pharmaceutical Announces New Executive Appointments
May 17, 2025: Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Ninth Consecutive Year
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net